GALT — Galectin Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapMomentum Trap

Annual balance sheet for Galectin Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	47.5	27.1	39.6	18.6	25.7
Prepaid Expenses
Total Current Assets	48.2	29.5	41.8	20.6	27.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.084	0.048	0.007	0.086	0.053
Other Long Term Assets
Total Assets	48.5	29.6	41.8	21.3	28.2
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	2.82	5.4	9.03	13	15.7
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.87	5.41	39.2	53.5	88.4
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	45.6	24.2	2.62	-32.2	-60.2
Total Liabilities & Shareholders' Equity	48.5	29.6	41.8	21.3	28.2
Total Common Shares Outstanding
Total Preferred Shares Outstanding